Advertisement

Topics

Latest Drug Discovery NewsRSS

06:30 EST 23rd November 2017 | BioPortfolio

MorphoSys Announces That Its Licensee Janssen Has Received Approval for Tremfya(R) (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis (news with additional features)

DGAP-News: MorphoSys AG / Key word(s): Regulatory Approval 23.11.2017 / 10:19 The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, November 23, 2017 MorphoSys Announces That Its Licensee Janssen Has Received Approval for Tremfya(R) (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis MorphoSys entitled to royalties...

Bioanalytical Systems Inc BASI Medical Equipment Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryBioanalytical Systems Inc Bioanalytical Systems is a provider of monitoring instruments. The company offers drug development programs which include preclinical toxicology, bioanalysis, bioequivalence analysis and clinical trial specimen collection kits. Its products comprise electrochemical detectors, analytical instruments, force plate actimeter, BASi Raturn and Culex NxT automated blood s...

Microbot Medical Inc MBOT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryMicrobot Medical Inc Microbot, formerly StemCells Inc, a subsidiary of Stem Cell Sciences UK Ltd, is a medical device company that develops pharmaceutical, cell based therapeutics and related tools. The company provides research on products for spinal cord injury, thoracic injury, cervical injury, retinal disorders, dry agerelated macular degeneration, neurodegenerative diseases, neuronal c...

Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - September 29, 2017

Message from the CEO IBT announced results from the safety and tolerability study of IBP-9414 on September 11th. The data demonstrate a similar safety and tolerability profile in the active and placebo groups. The study included 120 preterm infants, dosed during two weeks and evaluated at time points up to 6 months after administration of the study drug at 15 neonatal centers in ...

Saniona AB: Saniona AB's Nomination Committee for the 2018 Annual General Meeting

PRESS RELEASE November 23, 2017 The Annual General Meeting on May 23, 2017, resolved that a Nomination Committee shall be appointed before coming election and remuneration. The Nomination Committee shall comprise three members, which should be representative for the two largest shareholders as of last September, together with the Chairman of the Board of Directors. On September 30,...

Sunshine Coast Announces Planned Upgrades to Psycho-education Programs for Drug Rehab and Alcohol Treatment in Vancouver, BC

Sunshine Coast Health Centre is one of the top drug rehabilitation and alcohol treatment programs in British Columbia, with an intake office in Vancouver and treatment facility in Powell River. The Centre is announcing that Director of Strategic Development, Daniel Jordan, will be pursuing a Master's Degree. Vancouver, BC (PRWEB) November 23, 2017 Sunshine Coast Health Centre (https://www.sun...

#jobs #lifescience Sr. Clinical Documentation Associate

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sr. Clinical Documentation Associate .NY-Tarrytown, Job Summary and Essential Functions: Known for its scientific and operational excellence, Company is a leading science-based biopharmaceutical company that discovers, invents, develops, … Continue reading → Cet ar...

#jobs #lifescience Drug Safety Surveillance Physician

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Drug Safety Surveillance Physician .CA-San Francisco, Strategic Medical Physician PV Safety job. Global Role. San Francisco Bay. $240,000 with full relocation Your new company This established Rare Disease … Continue reading → Cet article #jobs #lifescience Drug Sa...

CMIC Holdings Co Ltd 2309 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryCMIC Holdings Co Ltd CMIC is a contract research organization that supports drug development services. The organization offers medical research related services to pharmaceuticals and medical organizations. Its CRO business services include monitoring, data management, STAT analysis, registration, eclinical trials, quality management, quality assurance, pharmacovigilance and medical writing...

Global Blood Therapeutics Inc GBT Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryGlobal Blood Therapeutics Inc GBT is a clinicalstage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous bloodbased disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment of sickle cell disease SCD is in Phase II clinical trial statge. Its GBT440 is a hemoglobin modifier which...

Biotech Reading List (November 2017)

Painful Truth: Successful Failure Of A Biotech StartupBruce Booth (LifeSciVC) The Wonder Drug for Aging (Made From One of the Deadliest Toxins on Earth)Cynthia Koons (Bloomberg) To save a young woman besieged by superbugs, scientists hunt a killer virusEric Boodman (STAT News) The Drug Project LandscapeDerek Lowe (In the Pipeline) A Zombie Gene Protects Elephants From CancerViv...

Endocyte Inc ECYT Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryEndocyte Inc Endocyte is a biopharmaceutical company which develops targeted therapies for the treatment of cancer and inflammatory diseases. The company's pipeline products include EC1456, EC2629 used to treat solid tumors; EC1169, EC0652 targets prostate cancer; Vintafolide EC145 for cancer; EC2319 used to treat inflammatorydiseases; EC0371 for the treatment of polycystickidneydisease. ...

Angle PLC Announces Collaboration With Philips in Breast and Rectal Cancer

GUILDFORD, SURREY -- (Marketwired) -- 11/23/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY) ANGLE plc ("the Company") COLLABORATION WITH PHILIPS IN BREAST AND RECTAL CANCER ANGLE to receive European research grants of £ 0.4 million ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is pleased to announce that it has established a collaboration with Philips to develop l...

Rockland Immunochemicals Inc Medical Equipment Deals and Alliances Profile [Report Updated: 08112017] Prices from USD $250

SummaryRockland Immunochemicals Inc Rockland is a biotechnology company which manufactures research tools for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. The company's products include primary antibodies, secondary antibodies, collagen products, EpiPlus, GFP Antibodies, blocking buffers, blood products, proteins and peptides, signaling anti...

Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference

DUBLIN, Ireland, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan arenas, today announced that members of its senior management team will present and participate in the Evercore ISI Biopharma Catalyst/Deep Dive Con...

Molecular Partners AG MOLN Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryMolecular Partners AG Molecular Partners is a biopharmaceutical company that offers biological drugs. The company's advanced pipeline products comprise abicipar, a designed ankyrin repeat protein based antiangiogenic drug developed for diabetic macular edema and wet agerelated macular degeneration. It develops drugs on DARPin base technology and other product candidates. Molecular Partners ...

Global and China Contract Research Organization CRO Market Research by Company, Type Application 20132025 [Report Updated: 07112017] Prices from USD $2000

SummaryMarket Segment as follows:By Type Preclinical CRO Clinical Trial CROBy Application Biotechnology Medical Device IndustryBy Company Quintiles LabCorp Covance PPD Parexel ICON PRA inVentiv INC CRL Wuxi AppTecThe main contents of the report including:Section 1:Product definition, type and application, global and China market overview;Section 2:Global a...

Lab21 Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 08112017] Prices from USD $250

SummaryLab21 Ltd Lab21, a subsidiary of Novacyt SA is a clinical laboratory that provides clinical diagnostic testing services. The company develops molecular diagnostics for oncology, HIV and viral hepatitis, drug management needs; and diagnostic kits and reagents including syphilis, malaria, human cytomegalovirus, blood donor screening, virology, enzyme immunoassay, bulk material, febrile staine...

Marinus Pharmaceuticals Inc MRNS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112017] Prices from USD $250

SummaryMarinus Pharmaceuticals Inc Marinus is a clinical stage biopharmaceutical company which manufactures and commercializes therapeutics for the treatment of epilepsy, neuropsychiatric disorders and others diseases. The company's product comprise ganaxolone is a synthetic small molecule analog of a naturally produced neurosteroid which modulates overexcited neurons in the brain. It performs Pha...

Global and Asia Latanoprost Market Status and Future Forecast 20132023 [Report Updated: 15112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Global Hydrogenated Nitrile Butadiene Rubber HNBR Market Data List by Segment 20152022 [Report Updated: 13112017] Prices from USD $800

SnapshotScar formation postsurgery is a significant clinical problem that can lead to disability and disfigurement. Topical silicone has empirically been shown to have positive impact on hypertrophic scars and keloids. It may take from 3 months up to a year or more to improve an old scar, depending on the condition of the scar tissue.This report covers Hydrogenated Nitrile Butadiene Rubber HNBR ba...

Reliance Life Sciences Pvt Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryReliance Life Sciences Pvt Ltd Reliance Life Sciences, a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company's product portfolio includes plasma proteins, biosimilars, proteins, steroid, hormones, Active Pharmaceutical Ingredients API and Finished Dosage Forms FDFs and others. It also pro...

MEI Pharma Inc MEIP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryMEI Pharma Inc MEI, formerly Marshall Edwards Inc is an oncology company that offers clinical development of novel therapies for cancer. The company's drug candidates comprise pracinostat, an oral HDAC inhibitor which is intended for the treatment of acute myeloid leukemia, myelodysplastic syndrome and myelofibrosis. Its also develops ME344, a mitochondrial inhibitor for the treatment of HE...

GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor

GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor Safety data, including adverse events and laboratory data, were reviewed by the Data Safety Monitoring Board (DSMB) which recommended the continuation of the trial without any modifications Positive outcome, based on a large number of patients al...

FDA approves Glenmark’s generic Hailey Fe 1/20

David SalazarThe contraceptive had U.S. brand and generic sales of roughly $116.8 million, according to data from IQVIA for the 12 months ended September 2017.

Quick Search
Advertisement
 

review and buy Drug Discovery market research data and corporate reports here